CoChat

Opposing roles of eosinophils in cancer

Open access
Simon, Sonja C. S., Utikal, Jochen, Umansky, Viktor · 2019 · Cancer Immunology, Immunotherapy

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Abstract

Eosinophils are a subset of granulocytes mostly known for their ability to combat parasites and induce allergy. Although they were described to be related to cancer more than 100 years ago, their role in tumors is still undefined. Recent observations revealed that they display regulatory functions towards other immune cell subsets in the tumor microenvironment or direct cytotoxic functions against tumor cells, leading to either antitumor or protumor effects. This paradoxical role of eosinophils was suggested to be dependent on the different factors in the TME. In addition, the clinical relevance of these cells has been recently addressed. In most cases, the accumulation of eosinophils both in the tumor tissue, called tumor-associated tissue eosinophilia, and in the peripheral blood were reported to be prognostic markers for a better outcome of cancer patients. In immunotherapy of cancer, particularly in therapy with immune checkpoint inhibitors, eosinophils were even shown to be a potential predictive marker for a beneficial clinical response. A better understanding of their role in cancer progression will help to establish them as prognostic and predictive markers and to design strategies for targeting eosinophils.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00262-018-2255-4

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 110 references

Research works printed but not linked: 1

  1. Feldbausch F (1900) The occurrence of eosinophilic leukocytes in tumours. Archiv Fur Pathologische Anatomie Physiologie Fur Klinische Medicin 161(1):1–18

Cited by

See all 128

Metadata

Authors
Simon, S. C. S., Utikal, J., & Umansky, V.
Affiliations
German Cancer Research Center (DE)
Corresponding author
Umansky, Viktor
Venue
Cancer Immunology, Immunotherapy
Published
2018-10-09
Volume
68
Issue
5
Pages
823-833
ISSN
  • 0340-7004 (ISSN-L)
  • 1432-0851
OpenAlex
W2896948312
Cited by
128
References
110
Citations by year
2026: 8 · 2025: 6 · 2024: 17 · 2023: 14 · 2022: 23 · 2021: 30 · 2020: 21 · 2019: 9
FWCI
6.44
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Cancer Immunology Immunotherapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (RTG2099)
  • Deutsches Krebsforschungszentrum (CA181)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords
eosinophils, tumor microenvironment, antitumor immunity, tumor-associated tissue eosinophilia, prognostic factors, predictive biomarkers, immune checkpoint inhibitors, cancer immunotherapy, eosinophil-targeted therapy, granulocytes
MeSH terms
Cytotoxicity, Immunologic, Eosinophils, Humans, Hypersensitivity, Immunotherapy, Neoplasms, Parasitic Diseases, Prognosis, Biomarkers, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Opposing roles of eosinophils in cancer. https://app.cochat.ai/papers/10.1007/s00262-018-2255-4
The paper
Simon, S. C. S., Utikal, J., & Umansky, V. (2019). Opposing roles of eosinophils in cancer. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-018-2255-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.